NewsPrivate Equity13/07/2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Public Sector Pension Investment Board →PSP participated in Prime Medicine’s US-company Series B investor syndicate. The company announced $315 million of aggregate financing comprising a $115 million Series A and $200 million Series B. PSP was identified only in the Series B; individual economics were undisclosed.